Back to All Events

March 7, 2019

Zealand Pharma, Fourth Quarter and Full Year 2018, Conference Call

Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR no. 20 04 50 78) announces that it will host a conference call on March 7, 2019 at 4 pm CET/10 am EST following the announcement of its Q4 and FY 2018 results.

Interim Chief Executive Officer Adam Steensberg (effective March 1, 2019), and Executive Vice President and Chief Financial Officer Mats Blom, will lead the call, with the corporate management team in attendance. The presentation will be followed by a Q&A session. The conference call will be conducted in English, and the dial-in numbers are:

Denmark:..................... +45 32 72 80 42
United Kingdom:.......... +44 (0) 844 571 8892
United States:.............. +1 631 510 7495
Passcode..................... 5977587

A live audio webcast of the call, including an accompanying slide presentation, will be available via the following link, https://edge.media-server.com/m6/p/2ircikvb, and will be accessible on the Investor section of Zealand’s website (www.zealandpharma.com). Participants are advised to register for the webcast approximately 10 minutes before the scheduled start. A recording of the event and a transcript will be available on the Investor section of Zealand’s website after the call.

Earlier Event: March 5
March 5, 2019
Later Event: March 14
March 14, 2019